Key keywords: Nebius, NBIS stock, Q1 2024 earnings report, CapEx funding debate, NASDAQ:NBIS, cloud infrastructure investment, AI data center expansion, European public tech firm, shareholder dilution risk, unutilized credit facilities As one of Europe’s fastest-growing AI and cloud infrastructure providers, Nebius is set to release its first quarter 2024 earnings report on May 15, and market watchers agree that a single consolidated metric will end months of heated debate over how the company plans to fund its aggressive capital expenditure roadmap. Back in November 2023, Nebius leadership announced a €1.2 billion, 24-month expansion plan that includes building six new purpose-built AI data centers across Germany, France, and the Netherlands, aimed at capturing 8% of the regional AI training infrastructure market by 2026. The announcement immediately sparked a split among investors and analysts over the feasibility of funding the plan without heavy shareholder dilution, driving 18% price volatility for NBIS stock over the past 30 trading days alone. Bullish investors argue that Nebius’s existing €3 billion senior credit facility, combined with improving operating cash flows from its core cloud hosting business, will cover 100% of the planned CapEx without the need for secondary share offerings. They point to management’s repeated public comments that the firm will not issue new stock while its share price trades 12% below its latest net asset value per share, as it has for the past two months. Bearish analysts, by contrast, estimate that rising construction costs and longer-than-expected lead times for AI accelerator hardware will push CapEx requirements 22% above initial projections, forcing the company to issue new shares equivalent to 20% of its outstanding float to cover the gap, a move that would push NBIS’s share price down by an estimated 25% according to Goldman Sachs modeling. The single number set to settle the debate is the consolidated sum of Nebius’s Q1 free operating cash flow plus its unused available credit facility balance as of March 31, 2024. If the combined figure hits or exceeds €450 million, it will fully cover the first 18 months of committed CapEx spending, eliminating any near-term need for equity fundraising. Analysts at Morgan Stanley have set a $17 per share price target for NBIS if the figure comes in above €480 million, a 38% upside from its May 8 closing price of $12.34. If the combined figure falls below €400 million, however, the firm will be forced to either delay its expansion roadmap or pursue immediate equity funding, which would likely push the stock down to the $8 to $9 per share range, per consensus bear case forecasts. Trading volume for NBIS has risen 42% over the past week as retail and institutional investors position themselves ahead of the earnings release, with options data showing 62% of open contracts are betting on a positive post-earnings price move.